Introduction; Economic analysis of RSVpreF in pediatric populations; EtR Pfizer maternal RSV vaccine; Economic analysis of combined use of nirsevimab and maternal RSVpreF vaccine; Clinical considerations for RSV maternal vaccine and nirsevimab

This video can also be viewed at
https://www.cdc.gov/vaccines/videos/low-res/ACIPJune2023/ACIP-8_RSV_Pediatric_Maternal_06-22-2023-Day2_LowRes.mp4